Compare OPHC & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPHC | CPIX |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.1M | 98.3M |
| IPO Year | 2012 | 2007 |
| Metric | OPHC | CPIX |
|---|---|---|
| Price | $8.77 | $5.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.92 | N/A |
| AVG Volume (30 Days) | 57.7K | ★ 128.9K |
| Earning Date | 11-13-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.70 |
| EPS | ★ 0.48 | N/A |
| Revenue | N/A | ★ $42,010,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $18.65 | ★ N/A |
| Revenue Growth | N/A | ★ 16.75 |
| 52 Week Low | $3.97 | $1.85 |
| 52 Week High | $10.68 | $9.28 |
| Indicator | OPHC | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 44.81 | 42.65 |
| Support Level | $8.48 | $3.08 |
| Resistance Level | $9.28 | $6.32 |
| Average True Range (ATR) | 0.41 | 0.87 |
| MACD | -0.02 | -0.13 |
| Stochastic Oscillator | 27.45 | 23.50 |
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. The services provided by the bank include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, borrowings, repayment of loans, money market deposit accounts, debit cards, automated teller machines, and other bank related services.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.